• Atara Biotherapeutics (NASDAQ:ATRA) Earns Buy Rating from Analysts at Rodman & Renshaw

    Источник: Buzz FX / 20 дек 2024 08:52:12   America/New_York


    Atara Biotherapeutics (NASDAQ:ATRA) Earns Buy Rating from Analysts at Rodman & Renshaw Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Rodman & Renshaw began coverage on shares of Atara Biotherapeutics ( NASDAQ:ATRA
    Read more...
Опубликовать